This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Catechol-O-methyl transferase and expression of schizophrenia in 73 adults with 22q11 deletion syndrome.
Biological psychiatry · 2007
Clinical features of 78 adults with 22q11 Deletion Syndrome.
American journal of medical genetics. Part A · 2005
Latest funding
- $1,375,000
TRIAGE-GS: a randomized controlled trial of a genomics-first approach to rare disease diagnosis
CIHR · 2023 · Principal investigator
2 publications.
Catechol-O-methyl transferase and expression of schizophrenia in 73 adults with 22q11 deletion syndrome.
Bassett AS, Caluseriu O, Weksberg R, Young DA, Chow EW
Clinical features of 78 adults with 22q11 Deletion Syndrome.
Bassett AS, Chow EW, Husted J, Weksberg R, Caluseriu O, Webb GD, Gatzoulis MA
TRIAGE-GS: a randomized controlled trial of a genomics-first approach to rare disease diagnosis
Principal investigators: Costain, Gregory; Caluseriu, Oana; Kim, Raymond; Boycott, Kym M
Keywords: Care Pathway; Diagnostics; Economic Impact; Genome Sequencing; Genomic Testing; Health Outcomes; Randomized Controlled Trial; Rare Diseases
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.